Global Breast Biopsy Market Research and Forecast 2018-2023
A breast biopsy is a procedure in which tissues are removed from the affected or suspicious area. The removed cells are then examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is the only diagnostic procedure that can determine if the suspicious area is cancerous. Biopsy samples are sent to a laboratory for analysis where experts determine whether the cells are cancerous. The key factors contributing to the growth of the global breast biopsy market include high prevalence of breast cancer, increasing breast cancer screening programs, rising adoption of minimal invasive breast biopsies and high expenditure on breast cancer research. High cost of procedure, risk and harmful effects of breast biopsy are restraining the market. Introduction of new technologies such as vacuum assisted biopsy and rising awareness among women are some opportunity for the market.
The global breast biopsy market is segmented on the basis of type, device and end user. Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy and others (lymph node and vacuum assisted biopsy. Surgical biopsy is further segmented into incisional and excisional. The core needle biopsy has the significant market during the forecast year and the vacuum assisted biopsy has the significant growth during the forecast year. The device market is segmented into biopsy needles, guidance systems, biopsy tables and localization wires. The end user segment is bifurcated into hospitals, diagnostic centre and research institute.
The global breast biopsy market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global breast biopsy market, followed by Europe. This is mainly due to high prevalence of breast cancer, rising adoption of minimal invasive breast biopsies significantly contributing towards the market growth in the region. The Asia pacific region is projected to exhibit the fastest growth in the global breast biopsy market over the forecast period. This is due to increasing breast cancer screening programs
Some of the key players operating in the global breast biopsy market are Hologic Inc., Becton, Dickinson and Company, F. Hoffmann-la Roche ltd., Leica biosystems and others. In order to sustain in the competitive market, these players adopt various strategies such as Acquisitions, mergers, expansions, joint ventures and product development for the growth of the market.
Research Methodology
The market study of breast biopsy market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Market Segmentation:
Global breast biopsy market is segmented on the basis of regional outlook and following segments:
1. Global Breast Biopsy Market Research and Analysis, By Type
2. Global Breast Biopsy Market Research and Analysis, By Device
3. Global Breast Biopsy Market Research and Analysis, By End User
4. Global Breast Biopsy Market Research and Analysis, By Region
THE REPORT COVERS:
The global breast biopsy market is segmented on the basis of type, device and end user. Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy and others (lymph node and vacuum assisted biopsy. Surgical biopsy is further segmented into incisional and excisional. The core needle biopsy has the significant market during the forecast year and the vacuum assisted biopsy has the significant growth during the forecast year. The device market is segmented into biopsy needles, guidance systems, biopsy tables and localization wires. The end user segment is bifurcated into hospitals, diagnostic centre and research institute.
The global breast biopsy market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global breast biopsy market, followed by Europe. This is mainly due to high prevalence of breast cancer, rising adoption of minimal invasive breast biopsies significantly contributing towards the market growth in the region. The Asia pacific region is projected to exhibit the fastest growth in the global breast biopsy market over the forecast period. This is due to increasing breast cancer screening programs
Some of the key players operating in the global breast biopsy market are Hologic Inc., Becton, Dickinson and Company, F. Hoffmann-la Roche ltd., Leica biosystems and others. In order to sustain in the competitive market, these players adopt various strategies such as Acquisitions, mergers, expansions, joint ventures and product development for the growth of the market.
Research Methodology
The market study of breast biopsy market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
- Financial reports of companies involved in the market
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalogue
Market Segmentation:
Global breast biopsy market is segmented on the basis of regional outlook and following segments:
1. Global Breast Biopsy Market Research and Analysis, By Type
2. Global Breast Biopsy Market Research and Analysis, By Device
3. Global Breast Biopsy Market Research and Analysis, By End User
4. Global Breast Biopsy Market Research and Analysis, By Region
THE REPORT COVERS:
- Comprehensive research methodology of global breast biopsy market.
- This report also includes detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global breast biopsy market.
- Insights about market determinants which are stimulating the global breast biopsy market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH PREVALENCE OF BREAST CANCER
3.1.2. INCREASING BREAST CANCER SCREENING PROGRAMS
3.1.3. RISING ADOPTION OF MINIMAL INVASIVE BREAST BIOPSIES
3.1.4. HIGH EXPENDITURE ON BREAST CANCER RESEARCH
3.2. RESTRAINT
3.2.1. HIGH COST OF PROCEDURE
3.2.2. RISK AND HARMFUL EFFECTS OF BREAST BIOPSY
3.3. OPPORTUNITY
3.3.1. INTRODUCTION OF NEW TECHNOLOGIES SUCH AS VACUUM ASSISTED BIOPSY
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL BREAST BIOPSY MARKET, BY TYPE
4.1.1. FINE NEEDLE BIOPSY
4.1.2. CORE NEEDLE BIOPSY
4.1.3. SURGICAL BIOPSY
4.1.4. OTHERS (LYMPH NODE AND VACUUM ASSISTED BIOPSY
4.1. GLOBAL BREAST BIOPSY MARKET, BY END USER
4.1.1. HOSPITALS
4.1.2. DIAGNOSTIC CENTRE
4.1.3. RESEARCH INSTITUTE
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY MARKET STRATEGIES
5.2. KEY COMPANY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. ARGON MEDICAL
7.2. BECTON DICKINSON AND COMPANY
7.3. BENETEC MEDICAL SYSTEMS
7.4. C. R. BARD, INC.
7.5. CIANNA MEDICAL
7.6. CIGNA
7.7. COOK MEDICAL
7.8. F. HOFFMANN-LA ROCHE LTD.,
7.9. HOLOGIC INC.
7.10. IMS GIOTTO S.P.A.
7.11. LEICA BIOSYSTEMS NUSSLOCH GMBH (DEVICOR MEDICAL PRODUCTS, INC.)
7.12. MEDTRONIC
7.13. NORAS MRI PRODUCTS
7.14. ONCOCYTE CORPORATION
7.15. PLANMED OY
7.16. SCION MEDICAL TECHNOLOGIES, LLC.
7.17. SOMATEX MEDICAL TECHNOLOGIES GMBH
7.18. TRIVITRON HEALTHCARE
7.19. UNITED MEDICAL SYSTEMS INC.
7.20. VIGEO HEALTHCARE SOLUTIONS
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH PREVALENCE OF BREAST CANCER
3.1.2. INCREASING BREAST CANCER SCREENING PROGRAMS
3.1.3. RISING ADOPTION OF MINIMAL INVASIVE BREAST BIOPSIES
3.1.4. HIGH EXPENDITURE ON BREAST CANCER RESEARCH
3.2. RESTRAINT
3.2.1. HIGH COST OF PROCEDURE
3.2.2. RISK AND HARMFUL EFFECTS OF BREAST BIOPSY
3.3. OPPORTUNITY
3.3.1. INTRODUCTION OF NEW TECHNOLOGIES SUCH AS VACUUM ASSISTED BIOPSY
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL BREAST BIOPSY MARKET, BY TYPE
4.1.1. FINE NEEDLE BIOPSY
4.1.2. CORE NEEDLE BIOPSY
4.1.3. SURGICAL BIOPSY
4.1.4. OTHERS (LYMPH NODE AND VACUUM ASSISTED BIOPSY
4.1. GLOBAL BREAST BIOPSY MARKET, BY END USER
4.1.1. HOSPITALS
4.1.2. DIAGNOSTIC CENTRE
4.1.3. RESEARCH INSTITUTE
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY MARKET STRATEGIES
5.2. KEY COMPANY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. ARGON MEDICAL
7.2. BECTON DICKINSON AND COMPANY
7.3. BENETEC MEDICAL SYSTEMS
7.4. C. R. BARD, INC.
7.5. CIANNA MEDICAL
7.6. CIGNA
7.7. COOK MEDICAL
7.8. F. HOFFMANN-LA ROCHE LTD.,
7.9. HOLOGIC INC.
7.10. IMS GIOTTO S.P.A.
7.11. LEICA BIOSYSTEMS NUSSLOCH GMBH (DEVICOR MEDICAL PRODUCTS, INC.)
7.12. MEDTRONIC
7.13. NORAS MRI PRODUCTS
7.14. ONCOCYTE CORPORATION
7.15. PLANMED OY
7.16. SCION MEDICAL TECHNOLOGIES, LLC.
7.17. SOMATEX MEDICAL TECHNOLOGIES GMBH
7.18. TRIVITRON HEALTHCARE
7.19. UNITED MEDICAL SYSTEMS INC.
7.20. VIGEO HEALTHCARE SOLUTIONS
LIST OF TABLES
Table 1 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLIONS)
Table 2 GLOBAL FINE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 3 GLOBAL CORE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 4 GLOBAL SURGICAL BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 5 GLOBAL OTHER BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 6 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLIONS)
Table 7 GLOBAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 8 GLOBAL GUIDANCE SYSTEMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 9 GLOBAL BIOPSY TABLES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 10 GLOBAL LOCALIZATION WIRES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 11 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLIONS)
Table 12 GLOBAL HOSPITAL MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 13 GLOBAL DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 14 GLOBAL RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 15 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
Table 16 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
Table 17 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 18 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 19 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 20 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
Table 21 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 22 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 23 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 24 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
Table 25 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 26 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 27 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 28 ROW BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 29 ROW BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 30 ROW BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 1 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLIONS)
Table 2 GLOBAL FINE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 3 GLOBAL CORE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 4 GLOBAL SURGICAL BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 5 GLOBAL OTHER BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 6 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLIONS)
Table 7 GLOBAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 8 GLOBAL GUIDANCE SYSTEMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 9 GLOBAL BIOPSY TABLES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 10 GLOBAL LOCALIZATION WIRES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 11 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLIONS)
Table 12 GLOBAL HOSPITAL MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 13 GLOBAL DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 14 GLOBAL RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLIONS)
Table 15 GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
Table 16 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
Table 17 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 18 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 19 NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 20 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
Table 21 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 22 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 23 EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 24 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
Table 25 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 26 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 27 APAC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
Table 28 ROW BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
Table 29 ROW BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
Table 30 ROW BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY DEVICE, 2017-2023 ($ MILLION)
LIST OF FIGURES
Figure 1 GLOBAL BREAST BIOPSY MARKET SHARE BY TYPE, 2017 VS 2023 (%)
Figure 2 GLOBAL BREAST BIOPSY MARKET SHARE BY END USER, 2017 VS 2023 (%)
Figure 3 GLOBAL BREAST BIOPSY MARKET SHARE BY DEVICE, 2017 VS 2023 (%)
Figure 4 NORTH AMERICA BREAST BIOPSY MARKET SHARE, 2017 VS 2023 (%)
Figure 5 US BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 6 CANADA BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 7 EUROPEAN BREAST BIOPSY MARKET SHARE, 2017 VS 2023 (%)
Figure 8 UK BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 9 FRANCE BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 10 GERMANY BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 11 ITALY BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 12 SPAIN BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 13 ROE BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 14 ASIA PACIFIC BREAST BIOPSY MARKET SHARE, 2017 VS 2023 (%)
Figure 15 INDIA BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 16 CHINA BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 17 JAPAN BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 18 ROAPAC BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 19 REST OF THE WORLD BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 1 GLOBAL BREAST BIOPSY MARKET SHARE BY TYPE, 2017 VS 2023 (%)
Figure 2 GLOBAL BREAST BIOPSY MARKET SHARE BY END USER, 2017 VS 2023 (%)
Figure 3 GLOBAL BREAST BIOPSY MARKET SHARE BY DEVICE, 2017 VS 2023 (%)
Figure 4 NORTH AMERICA BREAST BIOPSY MARKET SHARE, 2017 VS 2023 (%)
Figure 5 US BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 6 CANADA BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 7 EUROPEAN BREAST BIOPSY MARKET SHARE, 2017 VS 2023 (%)
Figure 8 UK BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 9 FRANCE BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 10 GERMANY BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 11 ITALY BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 12 SPAIN BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 13 ROE BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 14 ASIA PACIFIC BREAST BIOPSY MARKET SHARE, 2017 VS 2023 (%)
Figure 15 INDIA BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 16 CHINA BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 17 JAPAN BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 18 ROAPAC BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
Figure 19 REST OF THE WORLD BREAST BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
